U.S. flag

An official website of the United States government

NM_000203.5(IDUA):c.1469T>C (p.Leu490Pro) AND Hurler syndrome

Germline classification:
Pathogenic/Likely pathogenic (5 submissions)
Last evaluated:
May 22, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000173657.15

Allele description

NM_000203.5(IDUA):c.1469T>C (p.Leu490Pro)

Gene:
IDUA:alpha-L-iduronidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4p16.3
Genomic location:
Preferred name:
NM_000203.5(IDUA):c.1469T>C (p.Leu490Pro)
HGVS:
  • NC_000004.12:g.1003102T>C
  • NG_008103.1:g.21106T>C
  • NM_000203.4(IDUA):c.1469T>C
  • NM_000203.5:c.1469T>CMANE SELECT
  • NM_001363576.1:c.1073T>C
  • NP_000194.2:p.Leu490Pro
  • NP_000194.2:p.Leu490Pro
  • NP_001350505.1:p.Leu358Pro
  • LRG_1277t1:c.1469T>C
  • LRG_1277:g.21106T>C
  • LRG_1277p1:p.Leu490Pro
  • NC_000004.11:g.996890T>C
  • NM_000203.3:c.1469T>C
  • NM_000203.4(IDUA):c.1469T>C
  • NM_000203.4:c.1469T>C
  • NM_000203.5:c.1469T>C
  • NR_110313.1:n.1557T>C
  • P35475:p.Leu490Pro
Protein change:
L358P; LEU490PRO
Links:
UniProtKB: P35475#VAR_003374; OMIM: 252800.0012; dbSNP: rs121965027
NCBI 1000 Genomes Browser:
rs121965027
Molecular consequence:
  • NM_000203.5:c.1469T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001363576.1:c.1073T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_110313.1:n.1557T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Functional consequence:
Unknown function
Observations:
2

Condition(s)

Name:
Hurler syndrome
Synonyms:
MUCOPOLYSACCHARIDOSIS TYPE IH; Gargoylism, Hurler Syndrome
Identifiers:
MONDO: MONDO:0011758; MedGen: C0086795; OMIM: 607014

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000799455Counsyl
criteria provided, single submitter

(Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018))
Pathogenic
(Apr 18, 2018)
unknownclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link,

SCV001870413Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV0025217793billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 22, 2022)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

SCV003845954Molecular Biology Laboratory, Department of Zoology, Quaid-i-azam University
no assertion criteria provided
Pathogenicinheritedresearch

SCV004100363Neuberg Centre For Genomic Medicine, NCGM
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedinheritedyesnot providednot providednot providednot providednot providedresearch
not providedgermlineyes1not providednot provided1not providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
Hindugermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.

de Ruijter J, de Ru MH, Wagemans T, Ijlst L, Lund AM, Orchard PJ, Schaefer GB, Wijburg FA, van Vlies N.

Mol Genet Metab. 2012 Dec;107(4):705-10. doi: 10.1016/j.ymgme.2012.09.024. Epub 2012 Sep 28.

PubMed [citation]
PMID:
23084433

Enzyme replacement therapy in 12 patients with MPS I-H/S with homozygous p.Leu490Pro mutation.

Arora RS, Mercer J, Thornley M, Tylee K, Wraith JE.

J Inherit Metab Dis. 2007 Oct;30(5):821. Epub 2007 Jun 14.

PubMed [citation]
PMID:
17570076
See all PubMed Citations (9)

Details of each submission

From Counsyl, SCV000799455.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics, SCV001870413.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Hindu1not providednot providedclinical testing PubMed (1)

Description

A homozygous missense variant in exon 10 of the IDUA gene that results in the amino acid substitution of Proline for Leucine at codon 490 was detected. The observed variant c.1469T>C:p.(Leu490Pro) has not been reported in the 1000 genomes and has a MAF of 0.002% in the ExAC databases. The in silico prediction of the variant is damaging by PROVEAN and MutationTaster2. In summary, the variant meets our criteria to be classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From 3billion, SCV002521779.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (8)

Description

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.005%). Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID:23786846). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000011919). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID:11735025, 17570076, 21394825, 27146977, 28752568, 7550232). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least one similarly affected unrelated individual (PMID:, 21394825, 27146977, 28752568). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

From Molecular Biology Laboratory, Department of Zoology, Quaid-i-azam University, SCV003845954.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearchnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1inheritedyesnot providednot providednot providednot providednot providednot providednot provided

From Neuberg Centre For Genomic Medicine, NCGM, SCV004100363.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The missense variant p.L490P in IDUA (NM_000203.4) has been reported previously in multiple patients in homozygous state including those of Indian origin (Uttarilli A et al,2016). Although the variant is present at 0.0047% in gnomAD Exomes, it has the flag "Failed Random Forest" and may not represent the true population frequency. The p.L490P variant is novel (not in any individuals) in 1000 Genomes. There is a moderate physicochemical difference between leucine and proline. For these reasons, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024